Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs

Transplant International

Volumn 25, Issue 9, 2012, Pages 987-993

  Roodnat, Joke I ^a   Van De Wetering, Jacqueline ^a   Claas, Frans H ^b   Ijzermans, Jan ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

blood type O; eurotransplant; eurotransplant allocation system; highly sensitised; living donor kidney transplantation; PRA

Indexed keywords

ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP O; FEMALE; HEALTH PROGRAM; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; EUROPE; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; ORGAN TRANSPLANTATION; RENAL INSUFFICIENCY; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84864811797     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01526.x     Document Type: Article

References (25)

1. Klerk M, Witvliet MD, Haasse-Kromwijk JJM, Claas FHJ, Weimar W,. Hurdles, barriers, and, successes of a national living donor kidney-exchange program. Transplantation 2008; 86: 1749.
2. DeMeester J, Persijn GG, Wujciak T, Opelz G, Vanrenterghem Y,. The new Eurotransplant Kidney Allocation System: report one year after implementation. Eurotransplant International Foundation. Transplantation 1998; 9: 1154.
3. Wujciak T, Opelz G,. A proposal for improved cadaver kidney allocation. Transplantation 1993; 56: 1513.
4. ET Kidney Allocation System (ETKAS) Eurotransplant Manual version 1.8; February 28, 2011. https://www.eurotransplant.org/files/et-manual/Chapter4- thekidney.pdf
5. Claas FH, Rahmel A, Doxiadis I,. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 2009; 27; 88: 447.
6. Roodnat JI, Laging M, Massey EK, et al. Accumulation of unfavourable clinical and socioeconomic factors precludes living donor kidney transplantation. Transplantation 2012; 93: 518.
7. Roodnat JI, Kal-van Gestel JA, Zuidema W, et al. Successful expansion of the living donor pool by alternative living donation programs. Am J Transplantation 2009; 9: 2150.
8. Segev DL, Veale JL, Berger JC, et al. Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant 2011; 11: 356.
9. Roodnat JI, Zuidema W, van de Wetering J, et al. Altruistic donor triggered domino-paired kidney donation for unsuccessful couples from the kidney-exchange program. Am J Transplant 2010; 10: 821.
10. Huh KH, Kim MS, Ju MK, et al. Exchange living-donor kidney transplantation: merits and limitations. Transplantation 2008; 3: 430.
11. Gentry SE, Montgomery RA, Segev DL,. Kidney-paired donation: fundamentals, limitations, and expansions. Am J Kidney Dis 2011; 57: 144.
12. Glander P, Budde K, Schmidt D, et al. The 'blood group O problem' in kidney transplantation - time to change? Nephrol Dial Transplant 2010; 25: 1998.
13. Port FK, Hled PJ, Wolfe RA, Garcia JR, Rocher LL,. The impact of nonidentical ABO cadaveric renal transplantation on waiting times and graft survival. Am J Kidney Dis 1991; 17: 519.
14. Kranenburg LW, Zuidema W, Weimar W, et al. One donor, two transplants: willingness to participate in altruistically unbalanced exchange donation. Transpl Int 2006; 19: 995.
15. Wilpert J, Fischer KG, Pisarski P, et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transplant 2010; 25: 3778.
16. Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G,. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85: 1745.
17. Bryan CF, Nelson PW, Shield CF, et al. Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. Am J Transplant 2007; 7: 1181.
18. Bryan CF, Nelson PW, Shield Jr CF, et al. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. Clin Transpl 2004; 127.
19. Ross LF, Zenios S,. Restricting living-donor- cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit. Transplantation 2004; 5: 641.
20. http://optn.transplant.hrsa.gov/SharedContentDocuments/ KidneyConceptDocument.PDF
21. http://www.scandiatransplant.org/exchange-rules-30-jun-2010.pdf
22. Baran D,. http://www.ccdt.ca/english/publications/background-pdfs/ Deceased-Donor-Allocation.pdf
23. http://www.organdonation.nhs.uk/ukt/about-transplants/organ-allocation/ kidney-(renal)/renal-organ-sharing-principles/kidney-organ-allocation-scheme- 2006.jsp
24. Montgomery RA, Lonze BE, King KE, et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011; 365: 318.
25. Gloor J, Stegall MD,. Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol. 2010; 6: 297.